Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs. Warfarin in Left Ventricular Thrombus
NCT07709780Phase 3Recruiting
- Sponsor
- University of Arizona
- Start
- Jun 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in left ventricular thrombus (LVT), sponsored by University of Arizona. Started Jun 2026; status: recruiting.
02
Drugs
apixaban
03
Conditions
left ventricular thrombus (LVT)
Beyond the preview
Go deeper on NCT07709780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07709780.